Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia
dc.citation.epage | 373 | en_US |
dc.citation.issueNumber | 5 | en_US |
dc.citation.spage | 370 | en_US |
dc.citation.volumeNumber | 81 | en_US |
dc.contributor.author | Ataergin, S. | en_US |
dc.contributor.author | Arpaci, F. | en_US |
dc.contributor.author | Cetin, T. | en_US |
dc.contributor.author | Guran, s. | en_US |
dc.contributor.author | Yakicier, C. | en_US |
dc.contributor.author | Beyzadeoglu, M. | en_US |
dc.contributor.author | Ozet, A. | en_US |
dc.date.accessioned | 2019-02-08T11:47:18Z | |
dc.date.available | 2019-02-08T11:47:18Z | |
dc.date.issued | 2006 | en_US |
dc.department | Department of Molecular Biology and Genetics | en_US |
dc.description.abstract | A 38‐year‐old female with chronic myeloid leukemia underwent an allogeneic bone marrow transplantation from her full‐matched brother. Eleven months later, she readmitted with an acute leukemia that was shown to be of donor origin. The patient never achieved a remission even after chemotherapies with cytarabine and mitoxantrone, donor lymphocyte infusion, and second allogeneic peripheral blood stem cell transplantation. Donor cell leukemia (DCL) is sometimes misdiagnosed as relapse by clinicians and the real incidence may be higher than expected. Cytogenetic and molecular techniques may be helpful to clarify the issue of the leukemia. The current case is another case of DCL reported in the literature after an allogeneic transplant for a kind of leukemia. Am. J. Hematol. 81:370–373, 2006 | en_US |
dc.description.provenance | Submitted by Osman Bilgin (bosman@bilkent.edu.tr) on 2019-02-08T11:47:18Z No. of bitstreams: 1 Donor_Cell_Leukemia_in_a_Patient_Developing_11_months_After_an_Allogeneic_Bone_Marrow_Transplantation_for_Chronic_Myeloid_Leukemia.pdf: 75479 bytes, checksum: 6c5c81aa74acbab5611d7bb4e1fac8f0 (MD5) | en |
dc.description.provenance | Made available in DSpace on 2019-02-08T11:47:18Z (GMT). No. of bitstreams: 1 Donor_Cell_Leukemia_in_a_Patient_Developing_11_months_After_an_Allogeneic_Bone_Marrow_Transplantation_for_Chronic_Myeloid_Leukemia.pdf: 75479 bytes, checksum: 6c5c81aa74acbab5611d7bb4e1fac8f0 (MD5) Previous issue date: 2006 | en |
dc.identifier.doi | 10.1002/ajh.20615 | en_US |
dc.identifier.eissn | 1096-8652 | |
dc.identifier.issn | 0361-8609 | |
dc.identifier.uri | http://hdl.handle.net/11693/49157 | |
dc.language.iso | English | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | http://doi.org/10.1002/ajh.20615 | en_US |
dc.source.title | American Journal of Hematology | en_US |
dc.subject | Leukemia | en_US |
dc.subject | CML | en_US |
dc.subject | Donor cell | en_US |
dc.subject | Bone marrow transplantation | en_US |
dc.subject | TBI | en_US |
dc.title | Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Donor_Cell_Leukemia_in_a_Patient_Developing_11_months_After_an_Allogeneic_Bone_Marrow_Transplantation_for_Chronic_Myeloid_Leukemia.pdf
- Size:
- 73.71 KB
- Format:
- Adobe Portable Document Format
- Description:
- Full printable version
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: